MENU
+Compare
MNKD
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$5.76
Change
+$0.10 (+1.77%)
Capitalization
1.59B

MNKD MannKind Corp Forecast, Technical & Fundamental Analysis

a developer of therapeutic products

Industry Biotechnology
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MNKD with price predictions
Feb 18, 2025

MNKD sees MACD Histogram crosses below signal line

MNKD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 31, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MNKD as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MNKD entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MNKD advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

MNKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MNKD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (12.604). P/E Ratio (72.000) is within average values for comparable stocks, (85.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.581). MNKD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (6.002) is also within normal values, averaging (252.111).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MNKD is expected to report earnings to fall 50.00% to 2 cents per share on March 04

MannKind Corp MNKD Stock Earnings Reports
Q4'24
Est.
$0.03
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.01
Q4'23
Beat
by $0.02
The last earnings report on November 07 showed earnings per share of 5 cents, beating the estimate of 2 cents. With 1.93M shares outstanding, the current market capitalization sits at 1.59B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

MNKD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with TECH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
N/A
TECH - MNKD
41%
Loosely correlated
-0.99%
INSM - MNKD
40%
Loosely correlated
+2.58%
GBIO - MNKD
38%
Loosely correlated
+2.13%
SLDB - MNKD
36%
Loosely correlated
+31.51%
FULC - MNKD
36%
Loosely correlated
+2.17%
More